Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Syddansk Universitet Forside
Hjælp og FAQ
Dansk
English
Forside
Forskere
Forskningsenheder
Publikationer
Aktiviteter
Projekter
Datasæt
Presse/medie
Priser
Undervisning
Impacts
Søg efter ekspertise, navn eller tilknytning
Søren Hess offentligt CV
Vis Scopus-profil
Søren Hess
Klinisk lektor, Cheflæge
Klinisk Institut
Klinisk lektor
,
KI, OUH, Forskningsenhed for Klinisk fysiologi og nuklearmedicin (Odense)
https://orcid.org/0000-0003-1249-133X
E-mail
soeren.hess
rsyd
dk
Oversigt
Fingeraftryk
Netværk
Publikationer
(238)
Aktiviteter
(171)
Presse/medie
(19)
Lignende forskere
(12)
Ph.d.-vejledning
(3)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Søren Hess er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Fluorodeoxyglucose F 18
41%
Positron Emission Tomography
33%
Polyethylene Terephthalate
28%
Computer Assisted Tomography
28%
Cancer
25%
Systematic Review
21%
Fluorine-18
19%
Diseases
18%
Inflammatory Disorder
18%
Fluorodeoxyglucose
17%
Polymyalgia Rheumatica
16%
Pulmonary Embolism
15%
Malignant Neoplasm
15%
Infection
13%
Infectious Disease
13%
Bloodstream Infection
11%
Meta-Analysis
10%
Giant-Cell Arteritis
9%
Fever of Unknown Origin
9%
Colorectal Carcinoma
8%
Recurrent Disease
8%
Deoxyglucose
8%
Deep Vein Thrombosis
8%
Diagnostic Imaging
7%
Heart Left Ventricle Ejection Fraction
7%
Venous Thromboembolism
7%
Molecular Imaging
7%
Coronary Artery Disease
7%
Prostate Cancer
7%
Scintigraphy
6%
Vasculitis
6%
Standardized Uptake Value
6%
Radioactive Tracer
5%
Diagnostic Accuracy
5%
Magnetic Resonance Imaging
5%
Radioisotope
5%
Diagnostic Performance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Polyethylene Terephthalate
32%
Fluorodeoxyglucose F 18
25%
Rheumatic Polymyalgia
14%
Infection
10%
Giant Cell Arteritis
9%
Diseases
8%
Inflammation
8%
Fluorine 18
7%
Chronic Obstructive Lung Disease
7%
Fluorodeoxyglucose
6%
Malignant Neoplasm
5%
Prostate Cancer
5%
Recurrent Disease
5%
